The transaction is expected to close in the third quarter of this year and generate $286 million. Some of the product lines that Teleflex will divest include oxygen and aerosol therapy, active humidification, noninvasive ventilation, and incentive spirometers. These products generated $139 million in revenue in 2020. Teleflex entered the agreement with Medline to pay down debt and drive focus toward achieving long-term goals for the company.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
